Onconetix (ONCO) Registration filing summary

Management team and governance

• CEO is David A. White, who also serves as Principal Executive Officer and Interim Chief Financial Officer.

• Board includes Karina M. Fedasz (Chairman), Sammy Dorf, Sarah Romano, and Josh Epstein.

• Recent employment agreement executed with CEO David White in March 2026.

Offering details and pricing

• Registration covers resale of up to 25,000,000 shares of common stock, par value $0.00001 per share.

• Shares are to be offered by Keystone Capital Partners, LLC.

• Shares, when sold and issued, will be validly issued, fully paid, and non-assessable.

Underwriters and syndicate

• Ellenoff Grossman & Schole LLP acted as legal counsel for the registration.